Medindia

X

US District Court Returns Binding Verdict of Invalidity of Two Claims of Covidien Patent Covering Trocar Seal Technology

Tuesday, March 23, 2010 General News J E 4
Advertisement


ORANGE COUNTY, Calif., March 23 Applied Medical announced today that a United States District Court jury for the Eastern District of Texas returned a binding verdict of invalidity of two claims of a Covidien patent covering trocar seal technology.

Applied Medical also noted that the jury found Claim 6 of U.S. Patent No. 5,895,377 to be infringed by Applied Medical's older generation Kii(TM) and Universal® access systems. Applied Medical has progressed to a newer generation of Kii and Universal access systems. Moreover, Applied Medical believes the jury findings of infringement of the prior generation devices are contrary to the facts presented at trial. Applied Medical will continue to pursue post-trial motions seeking to overturn the infringement verdict.

"While we are pleased with the invalidity findings, we are disappointed that the jury returned an infringement verdict of '377 patent despite the evidence presented at trial. We maintain an unyielding belief that we have not infringed any valid U.S. patents," said Applied Medical's Surgical Group President, Gary Johnson.

About Applied Medical

Applied Medical is a new generation medical device company committed to the pursuit of sustainable, progressive health care solutions. Applied designs, manufactures and distributes innovative surgical products that enable enhanced patient outcomes while providing cost effective procedures and techniques. For more information, visit www.appliedmedical.com.

SOURCE Applied Medical
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Vascular Access Device Market in the U.S. to Reach...
S
The European Medicines Agency Completes Validation...